Showing results (981-990 of 1,797) with videos related to

Sort By:
Pageof 180
Mabs|February 5, 2014
Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycleOrnnuthchar Poungpair, Kunan Bangphoomi, Prapaipit Chaowalit, et al.
Mabs|February 5, 2014
Evaluation of human pancreatic RNase as effector molecule in a therapeutic antibody platformThomas Schirrmann, André Frenzel, Lars Linden, et al.
Mabs|February 5, 2014
Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune librarySebastian Miethe, Christine Rasetti-Escargueil, Yvonne Liu, et al.
Mabs|February 5, 2014
3D modeling and characterization of the human CD115 monoclonal antibody H27K15 epitope and design of a chimeric CD115 targetBenoît Grellier, Fabrice Le Pogam, Marc Vitorino, et al.
Mabs|February 5, 2014
Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2m(1) antibodyChristina Brunke, Stefan Lohse, Stefanie Derer, et al.
Mabs|January 20, 2025
Cost and supply considerations for antibody therapeuticsChun Chen, Zoe Garcia, David Chen, et al.
Mabs|January 30, 2025
Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidityJeremy Loyau, Thierry Monney, Marco Montefiori, et al.
Mabs|January 9, 2025
Predicting purification process fit of monoclonal antibodies using machine learningAndrew Maier, Minjeong Cha, Sean Burgess, et al.
Mabs|April 4, 2025
Proceedings of the 15th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Karien Bloem, Lysie Champion, et al.
Mabs|April 10, 2025
How to think about designing smart antibodies in the age of genAI: integrating biology, technology, and experienceAndrew Buchanan, Eric Bennett, Rebecca Croasdale-Wood, et al.
Pageof 180